Mustang Bio, Inc. (MBIO) Social Stream



Mustang Bio, Inc. (MBIO): $2.15

0.11 (-4.87%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add MBIO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#164 of 359

in industry

MUSTANG BIO INC (MBIO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering MUSTANG BIO INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-18 3 $13 $7 $10.4 $2.31 350.22%
2021-11-15 4 $13 $7 $10.4 $2.31 350.22%
2021-12-17 5 $13 $7 $9.8 $2.31 324.24%
2022-02-18 5 $11 $6 $8.4 $2.31 263.64%
2022-05-16 5 $8 $6 $7.25 $2.31 213.85%
2022-05-19 4 $8 $6 $7.25 $2.31 213.85%
2022-05-23 4 $8 $5 $7 $2.31 203.03%
2022-08-12 4 $8 $4 $6.75 $2.31 192.21%
2022-11-15 4 $8 $4 $6.25 $2.31 170.56%
2022-11-16 4 $7 $4 $5 $2.31 116.45%
2022-12-02 5 $7 $4 $5 $2.31 116.45%
2023-03-30 4 $7 $4 $5.25 $2.31 127.27%
2023-03-31 4 $104.947 $59.97 $71.214 $2.31 2982.86%
2023-05-15 4 $104.947 $26 $62.721 $2.31 2615.19%
2023-05-22 4 $59.97 $7 $36.235 $2.31 1468.61%
2023-05-23 4 $59.97 $18 $40.735 $2.31 1663.42%
2023-06-12 4 $59.97 $10 $28.242 $2.31 1122.6%
2023-08-15 4 $25 $10 $17.25 $2.31 646.75%

The Trend in the Analyst Price Target


MBIO's average price target has moved up $11.5 over the prior 12 months.

Over the past 39 weeks, MBIO's average upside potential has been 2,431.16%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-11-16 4 7.000 4.00 5.000 0.520 861.54%
2023-03-30 4 7.000 4.00 5.250 5.745 -8.62%
2023-03-31 4 104.947 59.97 71.214 0.367 19304.36%
2023-03-31 4 104.947 59.97 71.214 5.499 1195.04%
2023-08-15 4 25.000 10.00 17.250 3.800 353.95%

MBIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 13 months, MBIO's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, MUSTANG BIO INC's upside potential (average analyst target price relative to current price) is greater than 2062.33% of them.
  • To contextualize these metrics, consider that out of all US stocks, MUSTANG BIO INC's number of analysts covering the stock is greater than 366.13% of them.
  • In the context of all US stocks, MUSTANG BIO INC's average analyst price target is greater than 503.1% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, MUSTANG BIO INC's variance in analysts' estimates is lower than -1495.75% of them.

In the Pharmaceutical Products industry, ACET, KZIA, and VYNE are the three stocks most similar to MUSTANG BIO INC regarding the price target and analyst recommendation information presented here.

What is the outlook for MBIO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!